Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Mutation accumulation in somatic cells contributes to cancer development and is proposed as a cause of aging. DNA polymerases Pol ε and Pol δ replicate DNA during cell division. However, in some cancers, defective proofreading due to acquired POLE / POLD1 exonuclease domain mutations causes markedly...
Uložené v:
| Vydané v: | Nature genetics Ročník 53; číslo 10; s. 1434 - 1442 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
New York
Nature Publishing Group US
01.10.2021
Nature Publishing Group |
| Predmet: | |
| ISSN: | 1061-4036, 1546-1718, 1546-1718 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | Mutation accumulation in somatic cells contributes to cancer development and is proposed as a cause of aging. DNA polymerases Pol ε and Pol δ replicate DNA during cell division. However, in some cancers, defective proofreading due to acquired
POLE
/
POLD1
exonuclease domain mutations causes markedly elevated somatic mutation burdens with distinctive mutational signatures. Germline
POLE
/
POLD1
mutations cause familial cancer predisposition. Here, we sequenced normal tissue and tumor DNA from individuals with germline
POLE
/
POLD1
mutations. Increased mutation burdens with characteristic mutational signatures were found in normal adult somatic cell types, during early embryogenesis and in sperm. Thus human physiology can tolerate ubiquitously elevated mutation burdens. Except for increased cancer risk, individuals with germline
POLE
/
POLD1
mutations do not exhibit overt features of premature aging. These results do not support a model in which all features of aging are attributable to widespread cell malfunction directly resulting from somatic mutation burdens accrued during life.
Healthy tissues from individuals with germline mutations in
POLE
or
POLD1
show increased mutational burden, suggesting that normal cells are capable of tolerating high mutation rates. |
|---|---|
| Bibliografia: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 1061-4036 1546-1718 1546-1718 |
| DOI: | 10.1038/s41588-021-00930-y |